Bicycle Therapeutics plc
BCYC News Today: Stay Updated with the Latest Bicycle Therapeutics plc News in Real Time
Find BCYC news now at Meyka AI. Stay informed with the latest Bicycle Therapeutics plc stocks updates, including price news, market analysis, and expert insights.
4883.T Stock Surges 21% in Pre-Market Trading on May 1
Modalis Therapeutics (4883.T) jumps 21% in pre-market session on JPX. Stock price reaches ¥80 with volume spike to 35.4M shares.
LYG Lloyds Banking Group Earnings Beat: EPS Crushes Estimates
Lloyds Banking Group beat EPS estimates by 18% with $0.13 actual vs $0.11 expected, though revenue missed slightly at $6.46B.
GSK plc (GSK) Earnings Beat: Q1 2026 Results Exceed Expectations
GSK plc beat Q1 2026 earnings with $1.24 EPS vs $1.16 estimate and $10.30B revenue vs $10.23B forecast.
LOBE.CN stock surges 42% on April 30, 2026 as psychedelic biotech gains momentum
LOBE.CN stock jumps 42.1% to C$0.135 on April 30, 2026. Lobe Sciences Ltd. advances psilocybin therapeutics for PTSD and brain injuries.
AZN AstraZeneca Earnings Beat: Q1 2026 Results Exceed Expectations
AstraZeneca PLC (AZN) beat Q1 2026 earnings estimates with $2.58 EPS and $15.29B revenue, up 2.79% and 2.05% respectively.
BCYC: Jefferies Maintains Buy Rating, April 2026
Jefferies maintains Buy rating on Bicycle Therapeutics (BCYC) with price target lowered to $12 from $13.
RLF.SW Stock Bounces 0.87% on April 30 as Biotech Stabilizes
Relief Therapeutics (RLF.SW) gains 0.87% to CHF 2.885 on SIX. Biotech stock shows oversold bounce with 66,704 shares traded.
IDP.DE Biogen Inc. Earnings Beat: Q1 2026 Results
Biogen Inc. (IDP.DE) beats earnings expectations with $3.09 EPS and $2.14B revenue on April 29, 2026.
ALBPS.PA stock plunges 19.9% in after-hours trading on EURONEXT
Biophytis S.A. (ALBPS.PA) drops 19.9% in after-hours session on EURONEXT. Clinical-stage biotech faces steep decline amid market pressure.